Saturday 17 October 2026
Export CNTN’s income statement to Excel — free account
Canton Strategic Holdings, Inc.
CNTN Healthcare Biotechnology
In the quarter to June 2026, EPS grew 85.9% and free cash flow fell 600.4%, each against the same quarter a year earlier.
1.70
0.17
−9.09%
Follow CNTN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(225.01%) | (17.99%) | (34.42%) | (43.10%) | |
| (159.36%) | (13.74%) | (27.53%) | (34.60%) | ||
ROIC |
0.00% | (3.26%) | (7.94%) | (8.11%) | |
Return on Tangible Assets |
(167.66%) | (254.73%) | (192.44%) | (254.25%) | |
Free Cash Flow per Share |
(1.40) | (0.50) | (0.10) | (0.10) | |
Free Cash Flow |
(8.72) | (16.13) | (21.07) | (22.17) | |
| Other line items | |||||
Cash ROIC |
(63.19%) | (3.93%) | (4.12%) | (4.50%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(395.08) | (707.96) | — | — | |
Operating CF/Net income |
0.85 | 0.45 | 0.26 | 0.23 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.40) | (0.50) | (0.10) | (0.10) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates